Kryger Capital’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-243,303
Closed -$4.85M 41
2022
Q3
$4.85M Buy
+243,303
New +$3.21M 0.66% 21

Kryger Capital's FMTX Position: Q4 2022 in Review

Kryger Capital sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 243,303 shares — an estimated $4.85M sold.

Kryger Capital first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $4.85M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Kryger Capital reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Kryger Capital sold 243,303 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $4.85M.
  • Kryger Capital first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Kryger Capital's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $4.85M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Kryger Capital's 13F filing for Q4 2022, filed 14 Feb 2023.